Long-time Slashdot reader Baron_Yam quotes SciTechDaily:
A team of researchers at the Albert Einstein College of Medicine reveals the first compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach was directed against acute myeloid leukemia (AML) cells but may also have potential for attacking other types of cancers…. AML accounts for nearly one-third of all new leukemia cases and kills more than 10,000 Americans each year. The survival rate for patients has remained at about 30 percent for several decades, so better treatments are urgently needed.
The team’s computer screened a million compounds to determine the 500 most likely to bind to the “executioner protein” in cells. They then synthesized them all in their lab and evaluated their effectiveness.
Read more of this story at Slashdot.